Johnson & Johnson has announced the launch of two new products to meet the evolving needs of astigmatic patients in Europe and the Middle East – ACUVUE® OASYS MAX 1-Day Contact Lenses for Astigmatism – the first and only contact lens to optimise toric design according to cylinder power, and ACUVUE® OASYS MAX 1-Day MULTIFOCAL for Astigmatism – the first and only daily disposable multifocal contact lens for astigmatic presbyopes.
Designed to address the evolving needs of astigmatic patients, both lenses offer exceptional comfort, clarity and stability, plus crisp, clear vision at all distances and in all lighting conditions for presbyopes. Availability in the region will begin in select countries this September, with a further rollout in the following months.
With growing interest in comfortable and effective vision correction that meets evolving lifestyle needs, demand is rising for specialised contact lenses that address the needs of astigmatic patients with presbyopia.
Astigmatism affects about half of patients in at least one eye, making it one of the most common vision conditions. At the same time, it’s estimated that up to 2.1 billion people globally will develop presbyopia by 2030 due to our ageing population.
ACUVUE® OASYS MAX 1-Day for Astigmatism will be available in Italy, the United Kingdom, Ireland, Germany, Austria, Switzerland, France, the Nordics, Poland, Türkiye and GCC in 2025. ACUVUE® OASYS MAX 1-Day MULTIFOCAL for Astigmatism will be available in Italy, France and the Nordics in 2025. Both lenses will continue to be rolled out in additional countries in Europe and the Middle East throughout 2026.
